Navigation Links
Global E-Clinical Trial Technologies Industry
Date:8/30/2012

NEW YORK, Aug. 30, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global E-Clinical Trial Technologies Industry

http://www.reportlinker.com/p0960434/Global-E-Clinical-Trial-Technologies-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 80 companies including many key and niche players such as Aris Global, BioClinica, Clinipace Worldwide, Cmed Technology Ltd., DATATRAK International, Inc., DZS Software Solutions, Inc., eResearchTechnology, Inc., Medidata Solutions, Inc., Merge Healthcare, Inc., OmniComm Systems, Inc., Oracle Inc., Phase Forward, Inc., PAREXEL International Corporation, Perceptive Informatics, Inc., PharmaPros Corporation, Prelude Dynamics LLC, SAS Institute Inc., Target Health Inc., and Trianz Solutions. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

 

To order this report:

Drug_Discovery_and_Development Industry: Global E-Clinical Trial Technologies Industry

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Prenatal Diagnostics Industry
2. Global Needle-Free Drug Injection Systems and Safety Syringes Industry
3. Global High Content Screening (HCS) Industry
4. Global RFID in Healthcare and Pharmaceuticals Industry
5. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
6. Hologic To Participate In The Morgan Stanley Global Healthcare Conference
7. Bioquark, Inc. to Present at Rodman & Renshaw Annual Global Investment Conference
8. Watson to Present at the 2012 Bank of America Merrill Lynch Global Healthcare Conference
9. Global Nutraceuticals Industry
10. Global Dental Implants Industry
11. Global Artificial Implants Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/8/2017)... TEL AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. ... and immunology, today reports its financial results for the ... and achievements during the second quarter 2017 and to ... on multiple clinical development programs for the Company,s lead ... Phase 3 pivotal study with BL-8040 as novel stem ...
(Date:8/7/2017)... Md. , Aug. 7, 2017 ... healthcare member acquisition, retention, and engagement, announced the ... of Strategy and Product Development, effective as of ... consulting and technology implementation strategy for our clients. ... of experience in consulting and business analytics within ...
(Date:8/7/2017)... 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... as president, effective Aug. 7, 2017. ... to pursue other interests and will serve as president emeritus ... has served us in multiple leadership roles since he joined ... 2015 and has provided decisive, strategic leadership which continues to ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... Blue Health Intelligence (BHI) announced today ... Officer. Dr. Spiro brings over 30 years of clinical, healthcare IT, value-based care, and ... analytics solutions. , “I am thrilled to welcome Dr. Spiro to BHI,” said ...
(Date:8/16/2017)... ... 16, 2017 , ... The Data Council, the leading provider ... acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the Specialty, ... leading suppliers, brokers, distributors and retailers. The Data Council will become a part ...
(Date:8/16/2017)... York, New York (PRWEB) , ... August 16, 2017 , ... ... they could minimize its appearance with diet and exercise. In fact, cellulite can't always ... is a safer and more effective treatment available to select physicians nationwide. Dr. Kenneth ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Southeastern ... three-year grant totaling $975,000, renewing its funding from the Health Resources and Services ... This funding marks, the fourth time the HRSA administration has renewed its financial ...
(Date:8/16/2017)... , ... August 16, 2017 , ... With a new ... and ultimately, a cure. , The grants are awarded through a competitive application ... with a wide array of backgrounds and expertise in all areas relevant to PD ...
Breaking Medicine News(10 mins):